The second layer is an auxiliary diagnosis subsystem built on epidemiological characteristics, clinical symptoms, and 5 serum tumor markers of lung cancer, including ProGRP, VEGF, CEA, CYFRA21-1, and NSE, with an ANN model for searching suspected lung cancer patients from high-risk groups. This evidence concerns the gene ENO2 and lung carcinoma.